BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11544950)

  • 1. [Nuclear factor kappa B (NF-kappa B). II. Pathophysiologic meaning].
    Messer G; Rupec RA
    Hautarzt; 2001 Aug; 52(8):746-52; quiz 753-5. PubMed ID: 11544950
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of topical therapies and the rationale for combination therapy.
    Norris DA
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S17-25. PubMed ID: 15968260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
    Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The two-faced NF-kappaB in the skin.
    Sur I; Ulvmar M; Toftgård R
    Int Rev Immunol; 2008; 27(4):205-23. PubMed ID: 18574737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
    Baeuerle PA; Baichwal VR
    Adv Immunol; 1997; 65():111-37. PubMed ID: 9238509
    [No Abstract]   [Full Text] [Related]  

  • 6. NF-kappaB and inflammation in genetic disease.
    Sebban H; Courtois G
    Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kappaB inactivation.
    Yun KJ; Koh DJ; Kim SH; Park SJ; Ryu JH; Kim DG; Lee JY; Lee KT
    J Agric Food Chem; 2008 Nov; 56(21):10265-72. PubMed ID: 18841975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase.
    Kim YH; Lee SH; Lee JY; Choi SW; Park JW; Kwon TK
    Eur J Pharmacol; 2004 Jun; 494(1):1-9. PubMed ID: 15194445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS
    Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitric oxide pathway induction in human keratinocytes: role in cutaneous allergic and inflammatory phenomena].
    Bécherel PA; Chosidow O; Le Goff L; Debré P; Frances C; Arock M
    Ann Dermatol Venereol; 1997; 124(3):264-7. PubMed ID: 9686063
    [No Abstract]   [Full Text] [Related]  

  • 12. Unusual neonatal presentation of incontinentia pigmenti with persistent pulmonary hypertension of the newborn: a case report.
    Godambe S; McNamara P; Rajguru M; Hellmann J
    J Perinatol; 2005 Apr; 25(4):289-92. PubMed ID: 15789024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin.
    Lai CS; Li S; Chai CY; Lo CY; Dushenkov S; Ho CT; Pan MH; Wang YJ
    Carcinogenesis; 2008 Dec; 29(12):2415-24. PubMed ID: 18820286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
    Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Mar; 34(3):263-77. PubMed ID: 11945020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Medeiros R; Otuki MF; Avellar MC; Calixto JB
    Eur J Pharmacol; 2007 Mar; 559(2-3):227-35. PubMed ID: 17258194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
    Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
    J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
    J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum.
    Yoon YD; Han SB; Kang JS; Lee CW; Park SK; Lee HS; Kang JS; Kim HM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1873-82. PubMed ID: 14636836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.